Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...